Vault-13

DEERFIELD MANAGEMENT COMPANY, L.P.

New York, NY · CIK 1009258 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2012 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 86
Parsippany, NJUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
AnalystNew York, NY 2 $140,000
Data EngineerNew York, NY 1 $210,000
Senior Director, Business IntelligenceNew York, NY 1 $195,000
Director, Business IntelligenceNew York, NY 1 $180,000
Market Research AssociateNew York, NY 1 $80,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$6.0bn reported value +4.6% vs Q1 2024
433positions
51.5%in top 10
227 new 127 added 41 reduced 161 sold out vs Q1 2024

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 19,991,024 $1.5bn25.23% 25.23% UnchangedShares held: Q3 2023 20.0m, Q4 2023 20.0m, Q1 2024 20.0m, Q2 2024 20.0m
2 INSMED INC NOTE 1.750% 1/1 · principal INSM 1.75 01.15.25 · principal INSM 1.75 01.15.25 151,408,000 $258.7m4.30% 4.30% AddedPrincipal held: Q3 2023 108.9m, Q4 2023 117.0m, Q1 2024 117.0m, Q2 2024 151.4m +34.5m +34,454,000 29.5%
3 VIATRIS INC COM VTRS VTRS 21,395,496 $227.4m3.78% 3.78% AddedShares held: Q3 2023 19.9m, Q4 2023 19.9m, Q1 2024 21.4m, Q2 2024 21.4m +444 +444 0.0%
4 CENTENE CORP DEL COM CNC CNC 2,650,122 $175.7m2.92% 2.92% AddedShares held: Q3 2023 2.0m, Q4 2023 2.0m, Q1 2024 2.4m, Q2 2024 2.7m +269.1k +269,078 11.3%
5 INTEGRA LIFESCIENCES HLDGS C NOTE 0.500% 8/1 · principal IART 0.5 08.15.25 · principal IART 0.5 08.15.25 174,364,000 $164.5m2.74% 2.74% AddedPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 103.2m, Q2 2024 174.4m +71.1m +71,149,000 68.9%
6 BROOKDALE SR LIVING INC NOTE 2.000%10/1 · principal BKD 2 10.15.26 · principal BKD 2 10.15.26 161,905,000 $163.3m2.72% 2.72% UnchangedPrincipal held: Q3 2023 146.0m, Q4 2023 146.0m, Q1 2024 161.9m, Q2 2024 161.9m
7 MERUS N V COM MRUS MRUS 2,749,401 $162.7m2.71% 2.71% AddedShares held: Q3 2023 3.9m, Q4 2023 3.0m, Q1 2024 2.6m, Q2 2024 2.7m +100.0k +100,000 3.8%
8 LARIMAR THERAPEUTICS INC COM LRMR LRMR 21,231,974 $153.9m2.56% 2.56% UnchangedShares held: Q3 2023 16.9m, Q4 2023 16.9m, Q1 2024 21.2m, Q2 2024 21.2m
9 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 9,127,305 $141.4m2.35% 2.35% ReducedShares held: Q3 2023 8.2m, Q4 2023 8.9m, Q1 2024 9.1m, Q2 2024 9.1m -3.5k -3,512 -0.0%
10 ADAPTHEALTH CORP COMMON STOCK AHCO AHCO 13,257,940 $132.6m2.21% 2.21% UnchangedShares held: Q3 2023 13.6m, Q4 2023 13.6m, Q1 2024 13.3m, Q2 2024 13.3m
11 REVOLUTION MEDICINES INC COM RVMD RVMD 3,090,073 $119.9m2.00% 2.00% UnchangedShares held: Q3 2023 1.8m, Q4 2023 3.1m, Q1 2024 3.1m, Q2 2024 3.1m
12 ACCOLADE INC NOTE 0.500% 4/0 · principal ACCD 0.5 04.01.26 · principal ACCD 0.5 04.01.26 132,598,000 $115.5m1.92% 1.92% UnchangedPrincipal held: Q3 2023 132.6m, Q4 2023 132.6m, Q1 2024 132.6m, Q2 2024 132.6m
13 SURGERY PARTNERS INC COM SGRY SGRY 4,707,287 $112.0m1.86% 1.86% AddedShares held: Q3 2023 1.5m, Q4 2023 2.1m, Q1 2024 3.2m, Q2 2024 4.7m +1.5m +1,520,484 47.7%
14 KURA ONCOLOGY INC COM KURA KURA 5,411,571 $111.4m1.85% 1.85% UnchangedShares held: Q3 2023 4.4m, Q4 2023 5.3m, Q1 2024 5.4m, Q2 2024 5.4m
15 OSCAR HEALTH INC CL A OSCR OSCR 6,959,787 $110.1m1.83% 1.83% ReducedShares held: Q3 2023 0, Q4 2023 11.2m, Q1 2024 9.4m, Q2 2024 7.0m -2.4m -2,413,310 -25.8%
16 BROOKDALE SR LIVING INC COM BKD BKD 15,612,264 $106.6m1.77% 1.77% UnchangedShares held: Q3 2023 12.7m, Q4 2023 14.8m, Q1 2024 15.6m, Q2 2024 15.6m
17 WAYSTAR HLDG CORP COM WAY WAY 4,952,004 $106.5m1.77% 1.77% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 5.0m
18 GILEAD SCIENCES INC COM GILD GILD 1,491,000 $102.3m1.70% 1.70% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.5m
19 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 691,004 $95.1m1.58% 1.58% UnchangedShares held: Q3 2023 1.2m, Q4 2023 896.7k, Q1 2024 691.0k, Q2 2024 691.0k
20 ARS PHARMACEUTICALS INC COM SPRY SPRY 11,077,927 $94.3m1.57% 1.57% UnchangedShares held: Q3 2023 11.1m, Q4 2023 11.1m, Q1 2024 11.1m, Q2 2024 11.1m
21 MIRUM PHARMACEUTICALS INC NOTE 4.000% 5/0 · principal MIRM 4 05.01.29 · principal MIRM 4 05.01.29 70,000,000 $93.8m1.56% 1.56% NewPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 70.0m
22 OWENS & MINOR INC NEW COM ACH ACH 6,371,440 $86.0m1.43% 1.43% AddedShares held: Q3 2023 6.4m, Q4 2023 5.2m, Q1 2024 4.9m, Q2 2024 6.4m +1.5m +1,493,852 30.6%
23 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 10,901,485 $85.2m1.42% 1.42% AddedShares held: Q3 2023 2.7m, Q4 2023 3.5m, Q1 2024 8.3m, Q2 2024 10.9m +2.6m +2,630,788 31.8%
24 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,097,113 $73.6m1.23% 1.23% ReducedShares held: Q3 2023 2.3m, Q4 2023 2.6m, Q1 2024 2.6m, Q2 2024 2.1m -533.2k -533,179 -20.3%
25 HILLEVAX INC COM COM 4,004,231 $57.9m0.96% 0.96% UnchangedShares held: Q3 2023 4.0m, Q4 2023 4.0m, Q1 2024 4.0m, Q2 2024 4.0m
26 CVS HEALTH CORP COM CVS CVS 975,000 $57.6m0.96% 0.96% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 975.0k
27 CULLINAN THERAPEUTICS INC COM CGEM CGEM 3,280,237 $57.2m0.95% 0.95% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.1m, Q2 2024 3.3m +2.1m +2,141,706 188.1%
28 BAXTER INTL INC COM BAX BAX 1,577,647 $52.8m0.88% 0.88% AddedShares held: Q3 2023 0, Q4 2023 1.4m, Q1 2024 6.1k, Q2 2024 1.6m +1.6m +1,571,506 25590.4%
29 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,874,586 $51.8m0.86% 0.86% UnchangedShares held: Q3 2023 3.9m, Q4 2023 3.9m, Q1 2024 2.9m, Q2 2024 2.9m
30 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 8,135,804 $50.3m0.84% 0.84% AddedShares held: Q3 2023 3.3m, Q4 2023 4.5m, Q1 2024 5.0m, Q2 2024 8.1m +3.1m +3,140,804 62.9%
31 BIONTECH SE SPONSORED ADS BNTX BNTX 594,000 $47.7m0.79% 0.79% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 569.6k, Q2 2024 594.0k +24.4k +24,426 4.3%
32 DISC MEDICINE INC COM IRON IRON 1,023,265 $46.1m0.77% 0.77% AddedShares held: Q3 2023 430.0k, Q4 2023 464.3k, Q1 2024 665.5k, Q2 2024 1.0m +357.7k +357,730 53.8%
33 ENHABIT INC COM EHAB EHAB 4,997,746 $44.6m0.74% 0.74% UnchangedShares held: Q3 2023 5.0m, Q4 2023 5.0m, Q1 2024 5.0m, Q2 2024 5.0m
34 CONMED CORP COM CNMD CNMD 631,264 $43.8m0.73% 0.73% AddedShares held: Q3 2023 0, Q4 2023 2.6k, Q1 2024 338.2k, Q2 2024 631.3k +293.1k +293,099 86.7%
35 INTEGRA LIFESCIENCES HLDGS C COM NEW IART IART 1,467,632 $42.8m0.71% 0.71% ReducedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.5m, Q2 2024 1.5m -5.5k -5,458 -0.4%
36 BIO RAD LABS INC CL A BIO BIO 151,714 $41.4m0.69% 0.69% ReducedShares held: Q3 2023 173.9k, Q4 2023 151.6k, Q1 2024 152.4k, Q2 2024 151.7k -664 -664 -0.4%
37 DAY ONE BIOPHARMACEUTICALS I COM COM 2,923,137 $40.3m0.67% 0.67% AddedShares held: Q3 2023 1.3m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 2.9m +1.2m +1,157,825 65.6%
38 GALAPAGOS NV SPON ADR LKFT LKFT 1,411,000 $35.0m0.58% 0.58% UnchangedShares held: Q3 2023 0, Q4 2023 622.1k, Q1 2024 1.4m, Q2 2024 1.4m
39 EMBECTA CORP COMMON STOCK EMBC EMBC 2,726,135 $34.1m0.57% 0.57% UnchangedShares held: Q3 2023 0, Q4 2023 1.4m, Q1 2024 2.7m, Q2 2024 2.7m
40 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 844,407 $33.2m0.55% 0.55% ReducedShares held: Q3 2023 627.8k, Q4 2023 822.8k, Q1 2024 1.0m, Q2 2024 844.4k -189.3k -189,273 -18.3%
41 COGENT BIOSCIENCES INC COM COGT COGT 3,744,263 $31.6m0.53% 0.53% AddedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.5m, Q2 2024 3.7m +2.2m +2,209,918 144.0%
42 LANTHEUS HLDGS INC NOTE 2.625%12/1 · principal LNTH 2.625 12.15.27 · principal LNTH 2.625 12.15.27 25,255,000 $31.5m0.52% 0.52% UnchangedPrincipal held: Q3 2023 0, Q4 2023 0, Q1 2024 25.3m, Q2 2024 25.3m
43 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 119,800 $29.1m0.48% 0.48% NewShares held: Q3 2023 0, Q4 2023 1.6k, Q1 2024 0, Q2 2024 119.8k
44 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 2,817,763 $28.1m0.47% 0.47% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.8m
45 PHARVARIS N V COM PHVS PHVS 1,397,279 $26.3m0.44% 0.44% AddedShares held: Q3 2023 0, Q4 2023 812.2k, Q1 2024 1.1m, Q2 2024 1.4m +335.7k +335,687 31.6%
46 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 6,710,429 $24.2m0.40% 0.40% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 6.7m
47 INSULET CORP COM PODD PODD 112,433 $22.7m0.38% 0.38% AddedShares held: Q3 2023 127.0k, Q4 2023 178.9k, Q1 2024 110.1k, Q2 2024 112.4k +2.4k +2,372 2.2%
48 NKARTA INC COM NKTX NKTX 3,799,143 $22.5m0.37% 0.37% ReducedShares held: Q3 2023 0, Q4 2023 3.4m, Q1 2024 5.2m, Q2 2024 3.8m -1.4m -1,394,944 -26.9%
49 DOCGO INC COM DCGO DCGO 7,195,956 $22.2m0.37% 0.37% AddedShares held: Q3 2023 4.8m, Q4 2023 5.3m, Q1 2024 5.1m, Q2 2024 7.2m +2.1m +2,091,569 41.0%
50 INMODE LTD SHS INMD INMD 1,166,704 $21.3m0.35% 0.35% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.2m, Q2 2024 1.2m
51 PACS GROUP INC COM SHS PACS PACS 663,851 $19.6m0.33% 0.33% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 663.9k
52 LANTHEUS HLDGS INC COM LNTH LNTH 240,218 $19.3m0.32% 0.32% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 240.2k, Q2 2024 240.2k +31 +31 0.0%
53 CASTLE BIOSCIENCES INC COM CSTL CSTL 874,609 $19.0m0.32% 0.32% ReducedShares held: Q3 2023 946.6k, Q4 2023 965.4k, Q1 2024 928.0k, Q2 2024 874.6k -53.4k -53,408 -5.8%
54 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 869,250 $16.7m0.28% 0.28% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 667.0k, Q2 2024 869.2k +202.2k +202,250 30.3%
55 PRELUDE THERAPEUTICS INC COM PRLD PRLD 4,133,000 $15.7m0.26% 0.26% UnchangedShares held: Q3 2023 0, Q4 2023 4.1m, Q1 2024 4.1m, Q2 2024 4.1m
56 KYVERNA THERAPEUTICS INC COM KYTX KYTX 1,983,000 $14.9m0.25% 0.25% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.5m, Q2 2024 2.0m +520.7k +520,663 35.6%
57 FOGHORN THERAPEUTICS INC COM FHTX FHTX 2,518,500 $14.5m0.24% 0.24% NewShares held: Q3 2023 777.5k, Q4 2023 0, Q1 2024 0, Q2 2024 2.5m
58 CG ONCOLOGY INC COM CGON CGON 433,540 $13.7m0.23% 0.23% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 47.5k, Q2 2024 433.5k +386.0k +386,000 812.0%
59 VENTYX BIOSCIENCES INC COM VTYX VTYX 5,829,570 $13.5m0.22% 0.22% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.5m, Q2 2024 5.8m +2.3m +2,287,570 64.6%
60 TANGO THERAPEUTICS INC COM TNGX TNGX 1,540,000 $13.2m0.22% 0.22% UnchangedShares held: Q3 2023 793.7k, Q4 2023 1.5m, Q1 2024 1.5m, Q2 2024 1.5m
61 APOGEE THERAPEUTICS INC COM COM 329,000 $12.9m0.22% 0.22% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 329.0k, Q2 2024 329.0k
62 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,639,000 $12.7m0.21% 0.21% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.6m, Q2 2024 3.6m
63 ACCOLADE INC COM ACCD ACCD 3,475,000 $12.4m0.21% 0.21% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.4m, Q2 2024 3.5m +1.1m +1,092,898 45.9%
64 FATE THERAPEUTICS INC COM FATE FATE 3,555,871 $11.7m0.19% 0.19% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.2m, Q2 2024 3.6m +1.4m +1,365,463 62.3%
65 10X GENOMICS INC CL A COM TXG TXG 597,000 $11.6m0.19% 0.19% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 597.0k
66 ITEOS THERAPEUTICS INC COM ITOS ITOS 723,000 $10.7m0.18% 0.18% UnchangedShares held: Q3 2023 723.0k, Q4 2023 723.0k, Q1 2024 723.0k, Q2 2024 723.0k
67 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 1,743,398 $9.9m0.16% 0.16% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.3m, Q2 2024 1.7m -517.0k -517,000 -22.9%
68 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 877,790 $7.6m0.13% 0.13% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 579.6k, Q2 2024 877.8k +298.2k +298,196 51.5%
69 NEOGENOMICS INC NOTE 1.250% 5/0 · principal NEO 1.25 05.01.25 · principal NEO 1.25 05.01.25 6,500,000 $6.3m0.10% 0.10% UnchangedPrincipal held: Q3 2023 6.5m, Q4 2023 6.5m, Q1 2024 6.5m, Q2 2024 6.5m
70 ALECTOR INC COM ALEC ALEC 1,148,326 $5.2m0.09% 0.09% AddedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.1m +75.5k +75,481 7.0%
71 PRIME MEDICINE INC COM PRME PRME 896,960 $4.6m0.08% 0.08% AddedShares held: Q3 2023 885.3k, Q4 2023 885.3k, Q1 2024 885.3k, Q2 2024 897.0k +11.6k +11,646 1.3%
72 PHREESIA INC COM PHR PHR 192,347 $4.1m0.07% 0.07% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 192.3k
73 CALCIMEDICA INC COM NEW COM NEW 1,000,000 $4.0m0.07% 0.07% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.0m, Q2 2024 1.0m
74 FRACTYL HEALTH INC COM COM 834,254 $3.6m0.06% 0.06% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 834.3k, Q2 2024 834.3k
75 CABALETTA BIO INC COM CABA CABA 464,252 $3.5m0.06% 0.06% ReducedShares held: Q3 2023 2.3m, Q4 2023 2.0m, Q1 2024 1.3m, Q2 2024 464.3k -794.4k -794,398 -63.1%
76 ANNEXON INC COM ANNX ANNX 583,913 $2.9m0.05% 0.05% UnchangedShares held: Q3 2023 583.9k, Q4 2023 583.9k, Q1 2024 583.9k, Q2 2024 583.9k
77 AEROVATE THERAPEUTICS INC COM COM 1,411,608 $2.3m0.04% 0.04% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.4m
78 QUAKER HOUGHTON COM KWR KWR 13,015 $2.2m0.04% 0.04% NewShares held: Q3 2023 0, Q4 2023 1.4k, Q1 2024 0, Q2 2024 13.0k
79 DARDEN RESTAURANTS INC COM DRI DRI 14,344 $2.2m0.04% 0.04% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 6.3k, Q2 2024 14.3k +8.0k +8,009 126.4%
80 JABIL INC COM JBL JBL 19,662 $2.1m0.04% 0.04% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 19.7k
81 BIOMX INC COM COM 6,110,098 $2.1m0.03% 0.03% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 6.1m, Q2 2024 6.1m
82 LOWES COS INC COM LOW LOW 8,113 $1.8m0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 8.1k
83 UNIVERSAL STAINLESS & ALLOY COM COM 65,060 $1.8m0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 65.1k
84 ZOETIS INC CL A ZTS ZTS 10,078 $1.7m0.03% 0.03% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 4.2k, Q2 2024 10.1k +5.9k +5,889 140.6%
85 INNODATA INC COM NEW INOD INOD 111,814 $1.7m0.03% 0.03% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 27.3k, Q2 2024 111.8k +84.5k +84,509 309.5%
86 CALAVO GROWERS INC COM COM 70,514 $1.6m0.03% 0.03% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 10.6k, Q2 2024 70.5k +59.9k +59,940 566.9%
87 HUMACYTE INC COM HUMA HUMA 322,851 $1.5m0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 322.9k
88 THE ONCOLOGY INSTITUTE INC COM STLN STLN 3,360,052 $1.5m0.03% 0.03% UnchangedShares held: Q3 2023 3.4m, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m
89 HEXCEL CORP NEW COM HXL HXL 23,879 $1.5m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 4.2k, Q1 2024 5.3k, Q2 2024 23.9k +18.6k +18,620 354.1%
90 CAREMAX INC CL A NEW CL A NEW 530,232 $1.5m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 529.1k, Q2 2024 530.2k +1.1k +1,124 0.2%
91 RESMED INC COM RMD RMD 7,576 $1.5m0.02% 0.02% NewShares held: Q3 2023 0, Q4 2023 1.4k, Q1 2024 0, Q2 2024 7.6k
92 COOPER COS INC COM COO COO 16,609 $1.4m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.1k, Q2 2024 16.6k +11.5k +11,466 222.9%
93 MATTHEWS INTL CORP CL A MATW MATW 57,723 $1.4m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 12.4k, Q2 2024 57.7k +45.3k +45,285 364.1%
94 INTUIT COM INTU INTU 2,197 $1.4m0.02% 0.02% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.2k
95 CARRIAGE SVCS INC COM CSV CSV 53,584 $1.4m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 11.4k, Q1 2024 18.0k, Q2 2024 53.6k +35.6k +35,605 198.0%
96 TELEDYNE TECHNOLOGIES INC COM TDY TDY 3,656 $1.4m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 976, Q2 2024 3.7k +2.7k +2,680 274.6%
97 SINGULAR GENOMICS SYSTEMS IN COM NEW COM NEW 166,162 $1.4m0.02% 0.02% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 166.2k
98 TRANSMEDICS GROUP INC COM TMDX TMDX 9,298 $1.4m0.02% 0.02% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 9.3k
99 USANA HEALTH SCIENCES INC COM USNA USNA 29,742 $1.3m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 7.5k, Q2 2024 29.7k +22.3k +22,251 297.0%
100 AMERICAS CAR-MART INC COM CRMT CRMT 22,267 $1.3m0.02% 0.02% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 4.0k, Q2 2024 22.3k +18.3k +18,290 459.9%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
FUSION PHARMACEUTICALS INC 6,401,000 $136.5m6.4m shares
DECIPHERA PHARMACEUTICALS IN DCPH DCPH 5,127,270 $80.7m5.1m shares
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 1,283,176 $63.2m1.3m shares
VIKING THERAPEUTICS INC VKTX VKTX 463,501 $38.0m463.5k shares
PERSPECTIVE THERAPEUTICS INC ISR ISR 28,177,636 $33.5m28.2m shares
VERASTEM INC VSTM VSTM 1,538,461 $18.2m1.5m shares
QUIDELORTHO CORP QDEL QDEL 348,000 $16.7m348.0k shares
GUARDANT HEALTH INC GH GH 791,735 $16.3m791.7k shares
ENGENE HOLDINGS INC 800,000 $13.6m800.0k shares
GENEDX HOLDINGS CORP WGS WGS 643,110 $5.9m643.1k shares
VIGIL NEUROSCIENCE INC VIGL VIGL 980,311 $3.3m980.3k shares
SINGULAR GENOMICS SYSTEMS IN 4,984,871 $2.6m5.0m shares
AMAZON COM INC AMZN AMZN 5,219 $941.4k5.2k shares
ELECTRONIC ARTS INC EA EA 6,602 $875.9k6.6k shares
API GROUP CORP APG APG 22,264 $874.3k22.3k shares
TD SYNNEX CORPORATION SNX SNX 7,188 $813.0k7.2k shares
POLARIS INC PII PII 7,960 $797.0k8.0k shares
N-ABLE INC NABL NABL 57,956 $757.5k58.0k shares
SKYWATER TECHNOLOGY INC 71,580 $728.0k71.6k shares
LEONARDO DRS INC DRS DRS 31,888 $704.4k31.9k shares
FTI CONSULTING INC FCN FCN 3,242 $681.8k3.2k shares
AMEDISYS INC AMED AMED 6,978 $643.1k7.0k shares
PENSKE AUTOMOTIVE GRP INC PAG PAG 3,859 $625.1k3.9k shares
STERICYCLE INC SRCL SRCL 11,437 $603.3k11.4k shares
VISA INC V V 2,137 $596.4k2.1k shares